Codexis (CDXS) Share-based Compensation (2010 - 2026)
Codexis (CDXS) recorded quarterly Share-based Compensation of $1.4 million in Q1 2026, down 35.09% quarter-over-quarter from $2.2 million in Q4 2025, and down 39.97% on a YoY basis from $2.4 million in Q1 2025.
Codexis (CDXS) Share-based Compensation (2010 - 2026) Analysis & Trends
Codexis' Share-based Compensation history runs 17 years deep, the most recent figure standing at $1.4 million for Q1 2026.
- In Q1 2026, Share-based Compensation fell 39.97% year-over-year to $1.4 million; the TTM figure through Mar 2026 stood at $8.7 million (down 29.46% YoY), while the FY2025 annual figure was $9.6 million, down 26.46% from the prior year.
- Share-based Compensation was $1.4 million for Q1 2026 at Codexis, down from $2.2 million in the prior quarter.
- In the past five years, Share-based Compensation ranged from a high of $4.7 million in Q2 2024 to a low of $1.4 million in Q1 2026.
- Historically, Share-based Compensation has averaged $2.9 million across 5 years, with a median of $2.7 million in 2024.
- The sharpest annual moves came in 2023 and 2024: Share-based Compensation plunged 49.61% in 2023, then surged 72.39% in 2024.
- A 5-year view of Share-based Compensation shows it stood at $2.9 million in 2022, then dropped by 26.2% to $2.2 million in 2023, then gained by 16.78% to $2.5 million in 2024, then declined by 12.91% to $2.2 million in 2025, then tumbled by 35.09% to $1.4 million in 2026.
- The last three Share-based Compensation figures came in at $1.4 million (Q1 2026), $2.2 million (Q4 2025), and $2.5 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | 305,000.00 |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 166.40 Mn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | 26.47 Mn |
| 10 | Codexis | 236.00 Mn | 170.86 Mn | 13.18 Mn | 1.43 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.43 Mn |
| Mar 31, 2026 | 1.43 Mn |
| Dec 31, 2025 | 2.20 Mn |
| Dec 31, 2025 | 2.20 Mn |
| Sep 30, 2025 | 2.51 Mn |
| Sep 30, 2025 | 2.51 Mn |
| Jun 30, 2025 | 2.53 Mn |
| Jun 30, 2025 | 2.53 Mn |
| Mar 31, 2025 | 2.38 Mn |
| Mar 31, 2025 | 2.38 Mn |
| Dec 31, 2024 | 2.53 Mn |
| Dec 31, 2024 | 2.53 Mn |
| Sep 30, 2024 | 2.71 Mn |
| Sep 30, 2024 | 2.71 Mn |
| Jun 30, 2024 | 4.68 Mn |
| Jun 30, 2024 | 4.68 Mn |
| Mar 31, 2024 | 3.17 Mn |
| Mar 31, 2024 | 3.17 Mn |
| Dec 31, 2023 | 2.16 Mn |
| Dec 31, 2023 | 2.16 Mn |